Skip to content

Anti-microbial, anti-inflammatory treatment of seborrheic dermatitis with single center, researcher blind, randomized controlled study

Anti-microbial, anti-inflammatory treatment of seborrheic dermatitis with single center, researcher blind, randomized controlled study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17013549
Enrollment
Unknown
Registered
2017-11-26
Start date
2017-11-27
Completion date
Unknown
Last updated
2017-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

seborrheic dermatitis

Interventions

A:Pimecrolimus Cream
B:Fusidic acid cream
C:LA ROCHE-POSAY TOLERIANE ULTRA

Sponsors

1st Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients with seborrheic dermatitis (skin lesions in the face) and healthy people (no skin related diseases, no skin lesions); aged 18 to 65 years old.

Exclusion criteria

Exclusion criteria: With history of using anti-fungal agents, antibiotics and corticosteroid agents on the skin in the last two weeks; With history of systematically used antibiotics, antifungal drugs, corticosteroid hormones, antihistamine drugs, estrogen, immunomotor, anti-androgen preparation and other therapeutic agents in last two months; Severe skin infections or combined with psoriasis will be excluded; Patients allergic to fusidic acid and pimecrolimus will be excluded; Women in pregnancy or lactation were excluded; Patients with serious cardiovascular disease, diabetic hypertension or severe immune function were excluded; Alcoholism, drug abusers and dependants will be excluded; Patients who cannot cooperate with the doctor effectively were excluded; Patients without signing the informed consent book were excluded; Patients participated in other clinical trials within last month will be excluded.

Design outcomes

Primary

MeasureTime frame
Skin barrier function;seborrheic dermatitis area severity index;skin flora;

Countries

China

Contacts

Public ContactXing-hua Gao

1st Hospital of China Medical University

gaobarry@hotmail.com+86 13940152467

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026